Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.05% cyclosporine for allergy-related dry eye
ChiCTR2100049498Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University Eye Hospital
- Start
- Aug 2021
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of cyclosporine in dry eye syndrome (DED) and allergic conjunctivitis (AC) (3 arms), sponsored by Tianjin Medical University Eye Hospital. Primary endpoints: Ocular Surface Disease Index Questionnaire, Clinical signs of ocular surface and 4 more. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)allergic conjunctivitis (AC)
Beyond the preview
Go deeper on ChiCTR2100049498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049498.